Translational Development Acquisition Corp. Ordinary Shares (TDAC) — Financial Flexibility Index
Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Financial Flexibility Index of -0.19x as of September 2025. Free cash flow of $-1.24 Million (operating CF $-1.24 Million minus capex $0.00) represents 0% of total liabilities ($6.46 Million). Also explore TDAC shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Translational Development Acquisition Corp. Ordinary Shares Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Translational Development Acquisition Corp. Ordinary Shares across 3 annual periods. See TDAC net asset quality score to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Translational Development Acquisition Corp. Ordinary Shares (2022–2024)
Year-by-year free cash flow to debt coverage for Translational Development Acquisition Corp. Ordinary Shares. For the full company profile including market capitalisation, see Translational Development Acquisition Co (TDAC) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.14x | $-851.44K | $-851.45K | $6.25 Million | ▼ -33948.2% |
| 2023 | 0.00x | $-204.00 | $-204.00 | $509.68K | ▲ +99.8% |
| 2022 | -0.21x | $-97.16K | $-97.16K | $459.34K | — |